| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.039 | 0.8 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.059 | 0.8 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |